J.P. Marvel Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.1M Sell
55,566
-49
-0.1% -$49.7K 7.25% 2
2025
Q4
$59.8M Hold
55,615
8.3% 2
2025
Q3
$42.4M Sell
55,615
-110
-0.2% -$81.9K 6.17% 4
2025
Q2
$43.4M Sell
55,725
-382
-0.7% -$297K 6.99% 2
2025
Q1
$46.3M Buy
56,107
+104
+0.2% +$86.5K 8.02% 2
2024
Q4
$43.2M Sell
56,003
-20
-0% -$16.6K 7.14% 3
2024
Q3
$49.6M Buy
56,023
+155
+0.3% +$139K 8.1% 2
2024
Q2
$50.6M Sell
55,868
-70
-0.1% -$56K 8.3% 2
2024
Q1
$43.5M Sell
55,938
-133
-0.2% -$94.7K 7.53% 2
2023
Q4
$32.7M Sell
56,071
-284
-0.5% -$166K 6.47% 3
2023
Q3
$30.3M Sell
56,355
-25
-0% -$12.9K 6.52% 3
2023
Q2
$26.4M Sell
56,380
-60
-0.1% -$25.2K 5.52% 3
2023
Q1
$19.4M Sell
56,440
-733
-1% -$247K 4.37% 5
2022
Q4
$20.9M Sell
57,173
-32
-0.1% -$11.3K 4.91% 3
2022
Q3
$18.5M Sell
57,205
-275
-0.5% -$87.1K 4.71% 4
2022
Q2
$18.6M Sell
57,480
-35
-0.1% -$10.5K 4.48% 4
2022
Q1
$16.5M Sell
57,515
-60
-0.1% -$15.4K 3.35% 7
2021
Q4
$15.9M Buy
57,575
+185
+0.3% +$46.9K 3.11% 8
2021
Q3
$13.3M Buy
57,390
+212
+0.4% +$52.3K 3.99% 8
2021
Q2
$13.1M Sell
57,178
-50
-0.1% -$10K 2.79% 10
2021
Q1
$10.7M Sell
57,228
-15
-0% -$2.93K 2.53% 14
2020
Q4
$9.66M Hold
57,243
2.5% 11
2020
Q3
$8.47M Hold
57,243
2.44% 13
2020
Q2
$9.4M Sell
57,243
-171
-0.3% -$26.2K 2.97% 10
2020
Q1
$7.96M Buy
57,414
+260
+0.5% +$35.7K 3.02% 12
2019
Q4
$7.51M Hold
57,154
2.17% 16
2019
Q3
$6.39M Buy
+57,154
New +$6.36M 2.05% 15
2019
Q1
$7.46M Hold
57,468
2.42% 15
2018
Q4
$6.65M Buy
+57,468
New +$6.42M 2.4% 17
2018
Q2
$4.91M Sell
57,478
-70
-0.1% -$5.75K 1.5% 25
2018
Q1
$4.45M Sell
57,548
-753
-1% -$60.6K 1.37% 30
2017
Q4
$4.92M Sell
58,301
-354
-0.6% -$30.1K 1.5% 27
2017
Q3
$5.02M Buy
58,655
+1,745
+3% +$143K 1.6% 24
2017
Q2
$4.68M Hold
56,910
1.55% 27
2017
Q1
$4.79M Buy
56,910
+166
+0.3% +$13.3K 1.58% 26
2016
Q4
$4.17M Hold
56,744
1.43% 30
2016
Q3
$4.55M Sell
56,744
-2,100
-4% -$168K 1.62% 26
2016
Q2
$4.63M Sell
58,844
-542
-0.9% -$40.8K 1.62% 27
2016
Q1
$4.28M Sell
59,386
-147
-0.2% -$11.1K 1.54% 28
2015
Q4
$5.02M Buy
+59,533
New +$4.94M 1.75% 22
2015
Q2
$5.02M Sell
60,123
-80
-0.1% -$6.1K 1.69% 25
2015
Q1
$4.37M Sell
60,203
-50
-0.1% -$3.56K 1.49% 28
2014
Q4
$4.16M Buy
60,253
+800
+1% +$54K 1.45% 31
2014
Q3
$3.86M Sell
59,453
-407
-0.7% -$25.8K 1.4% 32
2014
Q2
$3.72M Buy
59,860
+520
+0.9% +$31K 1.27% 35
2014
Q1
$3.49M Buy
59,340
+1,930
+3% +$108K 1.23% 36
2013
Q4
$2.93M Buy
57,410
+1,550
+3% +$77.6K 1.05% 42
2013
Q3
$2.81M Sell
55,860
-10
-0% -$524 1.09% 43
2013
Q2
$2.74M Buy
+55,870
New +$3.04M 1.14% 41

Other funds holding LLY

J.P. Marvel Investment Advisors's LLY Position: Q1 2026 in Review

J.P. Marvel Investment Advisors reduced its Eli Lilly (LLY) stake by 0.09% in Q1 2026, selling an estimated $49.7K and leaving 55,566 shares worth $51.1M. The position accounts for 7.25% of the portfolio, ranked #2.

J.P. Marvel Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $59.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • J.P. Marvel Investment Advisors held 55,566 shares of Eli Lilly worth $51.1M as of Q1 2026.
  • J.P. Marvel Investment Advisors sold 49 Eli Lilly shares in Q1 2026, an estimated $49.7K.
  • Eli Lilly made up 7.25% of J.P. Marvel Investment Advisors's portfolio in Q1 2026, its #2 holding.
  • J.P. Marvel Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
  • J.P. Marvel Investment Advisors's Eli Lilly position peaked at $59.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on J.P. Marvel Investment Advisors's 13F filing for Q1 2026, filed 6 May 2026.